Stay Updated with the Latest Jio Financial Services Limited JIOFIN.BO News in Real Time
Find JIOFIN.BO news now at Meyka AI. Stay informed with the latest Jio Financial Services Limited stocks updates, including price news, market analysis, and expert insights.
Lido Staked ETH USD Rallies 5.9% to $2,462 as Momentum Indicators Flash Overbought
STETHUSD jumped 5.9% to $2,462.17 in 24 hours with RSI at 83.88 and price above Bollinger upper band, signaling extreme overbought conditions.
Toby Greene Weighs Free Agency Move to Victoria as GWS Season Ends, August 24
GWS Giants captain Toby Greene considers free agency move to Victoria after season ends. Coach Adam Kingsley hopeful he will stay but gives star forward time to decide.
XRP Surges 19.9% to $1.52 as RSI Hits Extreme Overbought 80
XRP USD jumped 19.9% to $1.5204 in 24 hours with RSI at 80.08, signaling extreme overbought conditions and a strong uptrend.
Taylor Sheridan Sued by Writer Over Yellowstone Copyright Claim, August 24
Writer Lauren J. Salkin sues Taylor Sheridan, claiming he stole Yellowstone from her 2016 Sovereign Nation pitch. Lawsuit seeks injunction and damages including profits from the hit series.
Ethereum Surges 5.9% to $2,464.69 as RSI Hits Extreme Overbought 84.7
Ethereum USD jumped 5.9% to $2,464.69 in 24 hours with RSI at 84.7, signaling extreme overbought conditions and a potential pullback.
Solana Climbs 8.5% to $95.08 as RSI Hits Extreme Overbought 78.7
Solana USD surged 8.5% to $95.08 in 24 hours with RSI at 78.7, signaling overbought conditions and potential pullback risk.
Zcash Surges 49.2% to $847.56 as RSI Hits Extreme Overbought 77.9
Zcash USD jumped 49.2% to $847.56 in 24 hours with RSI at 77.9 and volume 2.26x average, signaling extreme overbought conditions.
Take-Two Subpoenas Microsoft, Discord Over GTA 6 Leaks; TTWO Slides 0.2%
Take-Two subpoenas Microsoft and Discord to identify GTA 6 leakers. Nine gameplay videos released by CyberLeek group; game launches November 19. TTWO stock down 0.2%.
Moderna and Merck’s Melanoma Vaccine Jumps Stocks on Phase 3 Win
Moderna and Merck’s personalized mRNA cancer vaccine succeeded in Phase 3 melanoma trials, reducing disease recurrence. MRNA jumped 8.9% and MRK rose 2.4% on the announcement.